by Eric Christianson | Jan 8, 2023 | Clinical Guideline Updates For Pharmacists
The ADA has released its 2023 guidelines. There are a significant number of impacts on medication therapy, and in this post I will outline my most important takeaways. I was also recently catching up with my friend and fellow pharmacist, Derek Borkowski who is the...
by Eric Christianson | Dec 21, 2022 | Clinical Guideline Updates For Pharmacists
As the concerns surrounding opioid use have evolved, there have been more guidelines and organizations recommending guidance on prescribing practices of opioids. Today, we’ll be breaking down what you need to know from the 2022 CDC Opioid Guidelines’ recent...
by Eric Christianson | Nov 27, 2022 | Clinical Guideline Updates For Pharmacists
The Framingham risk score has been the primary method of determining a patient’s 10-year risk of cardiovascular disease. Scores such as this take into account a patient’s specific risk factors including age, gender, systolic blood pressure, total cholesterol,...
by Eric Christianson | Sep 4, 2022 | Clinical Guideline Updates For Pharmacists, Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Sexually transmitted infections (STIs) frequently come up in clinical practice and is also a frequent target for pharmacology and board exam questions! In this post, I will list my top 3 drugs to know and the sexually transmitted infections they treat. Below is a...
by Eric Christianson | Feb 20, 2022 | Clinical Guideline Updates For Pharmacists
I recently blogged about my thoughts on the new diabetes guidelines. After that post, my friend Derek Borkowski who is the founder of Pyrls.com messaged me to offer followers of the Meded101 blog a free download. He’s put together a phenomenal resource with his...
by Eric Christianson | Jan 12, 2022 | Clinical Guideline Updates For Pharmacists
The American Diabetes Association released their 2022 Diabetes Guidelines update. While I wouldn’t call the changes earth-shattering, there are some items in relation to pharmacotherapy that I feel are really important to note. The patient population that I work...
